Study design

prospective

Study time

2017-2018

Country

Netherlands

Object

Prostate cancer patients, newly diagnosed from 2017 to 2018 at 7 Dutch teaching hospitals were included. 

Sample size

1683

Topic classification

Supplementary Examition，Prediction

Keypoint

Use of mp-MRI tumor stage for prostate cancer risk classification leads to upstaging in 1 of 3 patients. Mp-MRI ebles superior detection of nonorgan-confined disease compared with DRE, and should be the preferred tool for determining clinical tumor stage.

Year